Correlation Engine 2.0
Clear Search sequence regions


  • cancer (2)
  • cell (5)
  • drug antitumor (1)
  • glioma (1)
  • growth (1)
  • humans (1)
  • imides (4)
  • Sizes of these terms reflect their relevance to your search.

    This work describes the antiproliferative potential of 14 cyclic imides (methylphtalimides, carboxylic acid phtalimides and itaconimides) against several human cancer cell lines. The antiproliferative effect was evaluated using the sulforhodamine B assay. Although some compounds from methylphtalimide and carboxylic acid phtalimide classes exhibited a selective antiproliferative activity, the itaconimides (11-14) exhibited the best results, especially compound 14, which presented a TGI (concentration that produces total growth inhibition) value of 0.0043 μM against glioma (U251), being inactive against the non-tumor cell line (HaCat). Absorption, distribution, metabolism and excretion in silico evaluations suggest that these compounds are promising candidates.

    Citation

    Dorimar Stiz, Adriana Campos, Ana Lúcia Tasca Gois Ruiz, João Ernesto de Carvalho, Rogério Corrêa, Valdir Cechinel-Filho. Antiproliferative effect of synthetic cyclic imides (methylphtalimides, carboxylic acid phtalimides and itaconimides) against human cancer cell lines. Zeitschrift fur Naturforschung. C, Journal of biosciences. 2016 Nov 01;71(11-12):423-427

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27768587

    View Full Text